JPRN-jRCT2080221133未知2 期
Phase II study of ARQ 197 monotherapy for previously treated advanced/recurrent gastric cancer
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2010年6月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Japanese or Korean with voluntary written informed consent for study participation
- •- A histologically or cytologically confirmed advanced/recurrent gastric cancer
- •- One or two prior chemotherapy regimens for advanced/recurrent gastric cancer
- •- At least one measurable lesion
- •- ECOG performance status of 0 or 1
- •- Life expectancy =< months
排除标准
- •- Surgery for cancer within 4 weeks prior to the first dose of ARQ 197
- •- Confirmed other tumors than gastric cancer within 5 years prior to the first dose of ARQ 197
- •- Anticancer chemotherapy, hormone therapy, radiotherapy or immunotherapy within 2 weeks prior to the first dose of ARQ 197
- •- Positive for HIV antibody
- •- Known symptomatic brain metastasis
- •- Gastrointestinal disorders that could interfere with the absorption of ARQ 197 or operation history for gastrointestinal disorders
- •- Uncontrolled concomitant disease
- •- Patients who wish to have a child and who would not agree to use contraceptive measures
- •- Pregnant or lactating
研究者
相似试验
已完成
2 期
Study of ARQ 197 MonotherapyGastric CancerNCT01152645Kyowa Kirin Co., Ltd.31
进行中（未招募）
1 期
A Randomized Controlled Phase 2 Trial of ARQ 197 inPatients with Unresectable Hepatocellular Carcinoma(HCC) Who Have Failed One Prior Systemic Therapynresectable hepatocellular carcinoma (HCC)MedDRA version: 14.0Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-007155-27-BEArQule, Inc.99
进行中（未招募）
不适用
A Randomized Controlled Phase 2 Trial of ARQ 197 inPatients with Unresectable Hepatocellular Carcinoma(HCC) Who Have Failed One Prior Systemic Therapynresectable hepatocellular carcinoma (HCC)MedDRA version: 14.0Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-007155-27-DEArQule, Inc.99
进行中（未招募）
不适用
A Randomized Controlled Phase 2 Trial of ARQ 197 in Patients with Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy - NDEUCTR2008-007155-27-ITARQULE99
进行中（未招募）
不适用
A Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transcription Factor Associated TumorsEUCTR2009-011669-10-GBArQule, Inc.39